New study reveals benefits and risks of Ozempic and GLP-1 medications

A new study has found that Ozempic and other GLP-1 medications offer various health benefits, including reduced risks of neurocognitive disorders, addiction, and mental health issues. This expands their known uses beyond treating type 2 diabetes and obesity. However, the study also revealed potential risks, such as negative effects on the pancreas and kidneys, along with gastrointestinal problems. These findings highlight the importance of monitoring patients for serious side effects while using these medications. The research involved over two million veterans and was published in the journal Nature. It emphasizes the need for patients to discuss the pros and cons of GLP-1 drugs with their healthcare providers.